TY - JOUR
T1 - α-hemolysin activity of methicillin-susceptible Staphylococcus aureus predicts ventilator-associated pneumonia
AU - Stulik, Lukas
AU - Malafa, Stefan
AU - Hudcova, Jana
AU - Rouha, Harald
AU - Henics, Bence Z.
AU - Craven, Donald E.
AU - Sonnevend, Agnes M.
AU - Nagy, Eszter
N1 - Publisher Copyright:
Copyright © 2014 by the American Thoracic Society.
PY - 2014/11/15
Y1 - 2014/11/15
N2 - Rationale: Colonization of lower airways by Staphylococcus aureus is a risk factor for the development of ventilator-associated tracheobronchitis (VAT) and ventilator-associated pneumonia (VAP). However, little is known about the virulence factors of methicillin-sensitive and -resistant S. aureus (MSSA and MRSA) that may influence host colonization and progression to VAT and VAP. Objectives: We evaluated MRSA and MSSA endotracheal aspirates (ETA) for genotype and α-hemolysin activity in relation to the development of VAT and VAP. Methods: Serial S. aureus ETA isolates from ventilated patients were analyzed for methicillin resistance, molecular type by Multi-Locus Sequence Typing and spa-typing, and α-hemolysin activity by semiquantitative analysis of hemolysis on sheep blood agar and quantitative measurement of cytolysis ofhumanlung epithelial cells.The virulence of selected strainswas assessed in mice by intranasal challenge. Measurements and Main Results: We detected S. aureus from ETA samples in a quarter of the 231 ventilated patients analyzed; one-third of them developed VAP. VAP patients (n = 15) were mainly infected by MSSA strains (87%), whereas colonized individuals (n = 18) not progressing to disease mainly carried MRSA strains (68%). MSSA isolates from colonized or VAT patients exhibited significantly lower α-hemolysin activity than those from VAP cases; however, no such relationship was found with MRSA strains. α-Hemolysin activity of S. aureus isolates was predictive for virulence inmouse pneumonia model. Conclusions: MSSA strains with strong blood agar hemolysis and high α-hemolysin activity aremarkers for VAP, but not VAT, and might be considered in differential diagnosis and initiation of therapy.
AB - Rationale: Colonization of lower airways by Staphylococcus aureus is a risk factor for the development of ventilator-associated tracheobronchitis (VAT) and ventilator-associated pneumonia (VAP). However, little is known about the virulence factors of methicillin-sensitive and -resistant S. aureus (MSSA and MRSA) that may influence host colonization and progression to VAT and VAP. Objectives: We evaluated MRSA and MSSA endotracheal aspirates (ETA) for genotype and α-hemolysin activity in relation to the development of VAT and VAP. Methods: Serial S. aureus ETA isolates from ventilated patients were analyzed for methicillin resistance, molecular type by Multi-Locus Sequence Typing and spa-typing, and α-hemolysin activity by semiquantitative analysis of hemolysis on sheep blood agar and quantitative measurement of cytolysis ofhumanlung epithelial cells.The virulence of selected strainswas assessed in mice by intranasal challenge. Measurements and Main Results: We detected S. aureus from ETA samples in a quarter of the 231 ventilated patients analyzed; one-third of them developed VAP. VAP patients (n = 15) were mainly infected by MSSA strains (87%), whereas colonized individuals (n = 18) not progressing to disease mainly carried MRSA strains (68%). MSSA isolates from colonized or VAT patients exhibited significantly lower α-hemolysin activity than those from VAP cases; however, no such relationship was found with MRSA strains. α-Hemolysin activity of S. aureus isolates was predictive for virulence inmouse pneumonia model. Conclusions: MSSA strains with strong blood agar hemolysis and high α-hemolysin activity aremarkers for VAP, but not VAT, and might be considered in differential diagnosis and initiation of therapy.
KW - Biomarker
KW - Staphylococcus aureus
KW - Ventilator-associated pneumonia
KW - α-hemolysin
UR - http://www.scopus.com/inward/record.url?scp=84925365885&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925365885&partnerID=8YFLogxK
U2 - 10.1164/rccm.201406-1012OC
DO - 10.1164/rccm.201406-1012OC
M3 - Article
C2 - 25303310
AN - SCOPUS:84925365885
SN - 1073-449X
VL - 190
SP - 1139
EP - 1148
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 10
ER -